Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1985 Jan 1;100(1):317–321. doi: 10.1083/jcb.100.1.317

On the association of glycoprotein Ib and actin-binding protein in human platelets

PMCID: PMC2113466  PMID: 3155520

Abstract

Glycoprotein (GP) Ib was purified from lysates of human platelets prepared in the presence or absence of inhibitors of the endogenous calcium-activated neutral protease (CANP) by immunoaffinity chromatography, employing the GPIb-specific murine monoclonal antibody, AP1, coupled to Sepharose CL4B. When derived from lysates prepared in the presence of EDTA or leupeptin, the eluate from the AP1-affinity column contained a 240,000-260,000-mol-wt protein in addition to GPIb. In SDS PAGE, this protein was stained by Coomassie Blue R, but not by the periodic acid-Schiff reagent, and it was not labeled with 125I in intact platelets by the lactoperoxidase-catalyzed method. When derived from lysates prepared in the absence of CANP inhibitors, the eluate contained only GPIb and its proteolytic derivative, glycocalicin. A change in the electrophoretic mobility of GPIb consistent with its association with the 240,000-260,000-mol-wt protein was confirmed by crossed immunoelectrophoresis. By an immunoblot technique involving transfer of proteins eluted from the AP1-affinity column and separated by SDS PAGE onto a nitrocellulose membrane, the 240,000-260,000-mol-wt protein bound polyclonal goat antibody raised against rabbit macrophage actin-binding protein (ABP). On the basis of these results, we conclude the GPIb is tightly associated with ABP under conditions in which the endogenous CANP is inhibited, and that this apparent transmembrane complex of GPIb-ABP can be isolated in lysates of nonactivated human platelets.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clemetson K. J., McGregor J. L., James E., Dechavanne M., Lüscher E. F. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest. 1982 Aug;70(2):304–311. doi: 10.1172/JCI110618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clemetson K. J., Naim H. Y., Lüscher E. F. Relationship between glycocalicin and glycoprotein Ib of human platelets. Proc Natl Acad Sci U S A. 1981 May;78(5):2712–2716. doi: 10.1073/pnas.78.5.2712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coller B. S. Effects of tertiary amine local anesthetics on von Willebrand factor-dependent platelet function: alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s). Blood. 1982 Sep;60(3):731–743. [PubMed] [Google Scholar]
  4. Coller B. S., Peerschke E. I., Scudder L. E., Sullivan C. A. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 1983 Jan;61(1):99–110. [PubMed] [Google Scholar]
  5. Davies G. E., Palek J. Platelet protein organization: analysis by treatment with membrane-permeable cross-linking reagents. Blood. 1982 Mar;59(3):502–513. [PubMed] [Google Scholar]
  6. Fox J. E., Reynolds C. C., Phillips D. R. Calcium-dependent proteolysis occurs during platelet aggregation. J Biol Chem. 1983 Aug 25;258(16):9973–9981. [PubMed] [Google Scholar]
  7. Kunicki T. J., Pidard D., Rosa J. P., Nurden A. T. The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis. Blood. 1981 Aug;58(2):268–278. [PubMed] [Google Scholar]
  8. McGowan E. B., Yeo K. T., Detwiler T. C. The action of calcium-dependent protease on platelet surface glycoproteins. Arch Biochem Biophys. 1983 Nov;227(1):287–301. doi: 10.1016/0003-9861(83)90373-9. [DOI] [PubMed] [Google Scholar]
  9. Montgomery R. R., Kunicki T. J., Taves C., Pidard D., Corcoran M. Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest. 1983 Feb;71(2):385–389. doi: 10.1172/JCI110780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nachmias V. T., Sullender J. S., Fallon J. R. Effects of local anesthetics on human platelets: filopodial suppression and endogenous proteolysis. Blood. 1979 Jan;53(1):63–72. [PubMed] [Google Scholar]
  11. Nurden A. T., Caen J. P. The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets. Semin Hematol. 1979 Jul;16(3):234–250. [PubMed] [Google Scholar]
  12. Nurden A. T., Dupuis D., Kunicki T. J., Caen J. P. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest. 1981 May;67(5):1431–1440. doi: 10.1172/JCI110172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Okumura T., Hasitz M., Jamieson G. A. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem. 1978 May 25;253(10):3435–3443. [PubMed] [Google Scholar]
  14. Phillips D. R., Jakábová M. Ca2+-dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca2+. J Biol Chem. 1977 Aug 25;252(16):5602–5605. [PubMed] [Google Scholar]
  15. Pidard D., Montgomery R. R., Bennett J. S., Kunicki T. J. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem. 1983 Oct 25;258(20):12582–12586. [PubMed] [Google Scholar]
  16. Polley M. J., Leung L. L., Clark F. Y., Nachman R. L. Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med. 1981 Oct 1;154(4):1058–1068. doi: 10.1084/jem.154.4.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosenberg S., Stracher A., Lucas R. C. Isolation and characterization of actin and actin-binding protein from human platelets. J Cell Biol. 1981 Oct;91(1):201–211. doi: 10.1083/jcb.91.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ruggeri Z. M., De Marco L., Gatti L., Bader R., Montgomery R. R. Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983 Jul;72(1):1–12. doi: 10.1172/JCI110946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schullek J., Jordan J., Montgomery R. R. Interaction of von Willebrand factor with human platelets in the plasma milieu. J Clin Invest. 1984 Feb;73(2):421–428. doi: 10.1172/JCI111228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Solum N. O., Hagen I., Sletbakk T. Further evidence for glycocalicin being derived from a larger amphiphilic platelet membrane glycoprotein. Thromb Res. 1980 Jun 15;18(6):773–785. doi: 10.1016/0049-3848(80)90200-5. [DOI] [PubMed] [Google Scholar]
  21. Solum N. O., Olsen T. M., Gogstad G. O., Hagen I., Brosstad F. Demonstration of a new glycoprotein Ib-related component in platelet extracts prepared in the presence of leupeptin. Biochim Biophys Acta. 1983 Mar 23;729(1):53–61. doi: 10.1016/0005-2736(83)90455-8. [DOI] [PubMed] [Google Scholar]
  22. White G. C., 2nd Calcium-dependent proteins in platelets: response of calcium-activated protease in normal and thrombasthenic platelets to aggregating agents. Biochim Biophys Acta. 1980 Aug 1;631(1):130–138. doi: 10.1016/0304-4165(80)90061-6. [DOI] [PubMed] [Google Scholar]
  23. Yoshida N., Weksler B., Nachman R. Purification of human platelet calcium-activated protease. Effect on platelet and endothelial function. J Biol Chem. 1983 Jun 10;258(11):7168–7174. [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES